Z-2141-2013Class II
LeGoo Endovascular Occlusion Gel-1.0 mL LeGoo with 3 Cannula Pouch Product Number: CS-100 LeGoo is a...
Genzyme Corporation, A Sanofi Company / initiated 2013-06-21 / Terminated / root cause: manufacturing process
Genzyme Corporation, A Sanofi Company began a recall of LeGoo Endovascular Occlusion Gel-1.0 mL LeGoo with 3 Cannula Pouch Product Number: CS-100 LeGoo is a water-soluble, biocompatible polymer with reverse... on . FDA classified it as Class II and gives the reason as "Product contains particulates (fibers)". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.
Recall record
- Recall number
- Z-2141-2013
- Classification
- Class II
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Genzyme Corporation, A Sanofi Company
- Product
- LeGoo Endovascular Occlusion Gel-1.0 mL LeGoo with 3 Cannula Pouch Product Number: CS-100 LeGoo is a water-soluble, biocompatible polymer with reverse thermo-sensitive properties allowing it to be injected as a soft viscoelastic gel that forms an elastic plug within the vessel. LeGoo is indicated for temporary endovascular occlusion of blood vessels up to 4 mm in diameter below the neck.
- Product code
- OBC Occluder, Internal Vessel, Temporary
- Reason for recall
- Product contains particulates (fibers)
- Root cause tag
- manufacturing process
- FDA root cause
- Material/Component Contamination
- Action
- Genzyme sent a Medical Device Recall Notification letter dated June 21, 2013, to all affected customers. The letter identified the product, the problem, and the action to be taken by the customer. Customers were avised to immediately discontinue use of all lots of LeGoo Endovascular Occlusion Gel and return all LeGoo and return product with the shipping label and packing slip enclosed. syringes.Complete the reply card via fax (414) 459-8791. Customer with questions were instructed to call GENCO at 877-674-2087. For questions regarding this recall call 508-270-2285.
- Quantity in commerce
- 100 units
- Distribution
- Worldwide Distribution - USA (nationwide) and internationally to Austria, Belgium, Canada, Denmark, Egypt. Europe, Finland, France, Germany, Hong Kong, Ireland, Italy, Netherlands, Poland, Saudi Arabia, Slovena, Spain, Sweden, Switzerland, The Netherlands, Turkey, and UK.
- Product codes and lots
- All lot codes
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-2139-2013 | Class II | Terminated | Voluntary: Firm initiated | ||
| Z-2140-2013 | Class II | Terminated | Voluntary: Firm initiated | ||
| Z-2141-2013 | Class II | Terminated | Voluntary: Firm initiated | ||
| Z-2142-2013 | Class II | Terminated | Voluntary: Firm initiated | ||
| Z-2143-2013 | Class II | Terminated | Voluntary: Firm initiated | ||
| Z-2144-2013 | Class II | Terminated | Voluntary: Firm initiated | ||
| Z-2145-2013 | Class II | Terminated | Voluntary: Firm initiated | ||
| Z-2146-2013 | Class II | Terminated | Voluntary: Firm initiated | ||
| Z-2147-2013 | Class II | Terminated | Voluntary: Firm initiated | ||
| Z-2148-2013 | Class II | Terminated | Voluntary: Firm initiated | ||
| Z-2149-2013 | Class II | Terminated | Voluntary: Firm initiated | ||
| Z-2150-2013 | Class II | Terminated | Voluntary: Firm initiated | ||
| Z-2151-2013 | Class II | Terminated | Voluntary: Firm initiated | ||
| Z-2152-2013 | Class II | Terminated | Voluntary: Firm initiated | ||
| Z-2153-2013 | Class II | Terminated | Voluntary: Firm initiated | ||
| Z-2154-2013 | Class II | Terminated | Voluntary: Firm initiated | ||
| Z-2155-2013 | Class II | Terminated | Voluntary: Firm initiated | ||
| Z-2156-2013 | Class II | Terminated | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
